Directory of Stock Market Company
This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.
Search into NYSE and TSX
by quote, company name or key word
AEZ - Aeterna Zentaris Inc
AEterna Zentaris Inc., incorporated on September 12, 1990, is a drug development company specialized in oncology and endocrine therapy. The Company’s product pipeline encompasses compounds at all stages of development, from drug discovery through marketed products. The priorities in oncology are its Phase III program with perifosine in multiple myeloma and its Phase II program in multiple cancers, includi","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"
Aeterna Zentaris Inc News
Aeterna Zentaris Receives Notification from NASDAQ Relating to Minimum Bid Price
Sacramento Bee - May 17, 2012
Sacramento Bee - May 17, 2012
By AETERNA ZENTARIS INC. QUEBEC CITY, May 16, 2012 -- /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced today that it has received a notice from The NASDAQ Stock Market indicating that the Company's minimum bid ...
Today's small-cap stocks to watch
Globe and Mail - May 17, 2012
Globe and Mail - May 17, 2012
Pure Industrial Real Estate Trust AAR.UN-X announced it has entered into an agreement to acquire two fully leased, single tenant, income producing industrial properties for a total purchase price of $19.5-million.
Aeterna Zentaris Receives Notification from NASDAQ Relating to Minimum Bid Price
MarketWatch (press release) - May 16, 2012
MarketWatch (press release) - May 16, 2012
QUEBEC CITY, May 16, 2012 /PRNewswire via COMTEX/ -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TOR:CA:AEZ) (the "Company") announced today that it has received a notice fromThe NASDAQ Stock Market indicating that the Company's minimum bid price has fallen ...
Canadian earnings declared Wednesday: Wi-LAN, Torstar, Tim Hortons, RONA
Brandon Sun - May 9, 2012
Brandon Sun - May 9, 2012
Aeterna Zentaris Inc. (TSX:AEZ). First-quarter ended March 31, 2012, net loss US$11.5 million, net loss 11 cents per share; 2011, net loss $10.1 million, net loss 12 cents per share.
Aeterna Zentaris loss widens on higher finance costs
Reuters Canada - May 9, 2012
Reuters Canada - May 9, 2012
(Reuters) - Canadian drugmaker Aeterna Zentaris Inc (AEZ.TO: Quote) (AEZS.O: Quote) posted a wider first-quarter loss as finance costs soared.
Today's small-cap stocks to watch
Globe and Mail - May 9, 2012
Globe and Mail - May 9, 2012
Nevsun Resources Ltd. NSU-T which almost hit year lows yesterday, announced today strong financial and operational results for the first quarter ended March 31, 2012.
Aeterna Zentaris Reports First Quarter 2012 Financial and Operating Results
MarketWatch (press release) - May 9, 2012
MarketWatch (press release) - May 9, 2012
Aeterna Zentaris Inc. (NASDAQ:AEZS) (TOR:CA:AEZ) (the"Company"), today reported financial and operating results as at and for the first quarter ended March31, 2012.
Keryx Biopharmaceuticals says perifosine rights terminated, revert back to Aeterna - Proactive Investors USA & Canada
Aeterna Zentaris Reports First Quarter 2012 Financial and Operating Results
PR Newswire (press release) - May 9, 2012
PR Newswire (press release) - May 9, 2012
QUEBEC CITY, May 9, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), today reported financial and operating results as at and for the first quarter ended March 31, 2012.
Aeterna Zentaris Regains North American Rights for Perifosine from Keryx
MarketWatch (press release) - May 7, 2012
MarketWatch (press release) - May 7, 2012
Aeterna Zentaris Inc. (NASDAQ:AEZS) (TOR:CA:AEZ) (the "Company") today announced that it and Keryx Biopharmaceuticals, Inc. ("Keryx") (UTD:KERX) have agreed to terminate their license agreement with respect to perifosine, as a result of which Aeterna ...
Aeterna, Keryx End Perifosine License Pact; Aeterna To Continue Trials - Wall Street Journal
Aeterna Zentaris to Present at 11th Annual JMP Securities Research Conference ...
MarketWatch (press release) - May 3, 2012
MarketWatch (press release) - May 3, 2012
QUÉBEC CITY, May 3, 2012 /PRNewswire via COMTEX/ -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TOR:CA:AEZ) (the"Company") today announced that its Senior VP and Chief Medical Officer, Paul Blake MD, will be presenting a corporate overview at the 11th Annual ...
Aeterna Zentaris to Announce First Quarter 2012 Financial and Operating ... - PR Newswire (press release) TSX Media Coverage Selection of the best articles found in your favorit medias